Imeik Technology Development Co.,Ltd.
300896
Peringkat dalam Saham
#3853
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Harga Saham
$14.24
Kapitalisasi Pasar
$4.31B
Perubahan (1 hari)
-0.62%
Perubahan (1 tahun)
-39.56%
Negara
CN
Perdagangan Imeik Technology Development Co.,Ltd. (300896)
Kategori
Healthcare
Riwayat hasil dividen untuk Imeik Technology Development Co.,Ltd. (300896)
Hasil dividen (TTM) dari Imeik Technology Development Co.,Ltd. (simbol saham: 300896) per 2023-12-31: 1.63%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.71%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.71%
Riwayat hasil dividen untuk Imeik Technology Development Co.,Ltd. (300896) dari 2014 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | 1.90% | 108.79% |
| 2024 | 0.91% | -44.17% |
| 2023 | 1.63% | 213.46% |
| 2022 | 0.52% | 1.96% |
| 2021 | 0.51% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 0.15% | -34.78% |
| 2018 | 0.23% | 155.56% |
| 2017 | 0.09% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
| Perusahaan | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 2.70% |
FR
|
|
| 0.00% |
JP
|
|
| 2.10% |
US
|
|
| 0.00% |
CH
|
